Iran medicine shortages deepen as war, shipping restrictions continue
Iran is experiencing deepening medicine shortages, impacting ordinary citizens like Ali Mohseni, whose mother requires insulin. The scarcity and tripling of prices for essential medications are attributed to a combination of factors including maritime shipping disruptions, sanctions, inflation, a weakening rial, and direct damage to the pharmaceutical sector.

Briefing Summary
AI-generatedIran is experiencing deepening medicine shortages, impacting ordinary citizens like Ali Mohseni, whose mother requires insulin. The scarcity and tripling of prices for essential medications are attributed to a combination of factors including maritime shipping disruptions, sanctions, inflation, a weakening rial, and direct damage to the pharmaceutical sector. Health Minister Mohammad Reza Zafarghandi stated that 16 pharmaceutical factories and over 70 hospitals have been attacked since the conflict began, which he described as violations of humanitarian rules. One affected company, Tofigh Daru, which produces active pharmaceutical ingredients for critical treatments, reported missile strikes damaging its facilities, with its CEO believing the intent was to disrupt specialized medicine production.
Article analysis
Model · rule-basedKey claims
5 extractedTofigh Daru Research and Engineering Company reported three missile strikes on its main building on March 31, damaging facilities.
16 pharmaceutical factories and over 70 hospitals in Iran have been attacked since the war began.
Insulin pens in Iran have more than tripled in price and become scarce due to the ongoing conflict.
Navid Nobakht believes the attack on Tofigh Daru was intended to disrupt specialized medicine production and create shortages.
Medicine shortages in Iran are exacerbated by maritime shipping disruptions, sanctions, inflation, and a weakening rial.